{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T06:05:09Z","timestamp":1785477909596,"version":"3.56.0"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T00:00:00Z","timestamp":1587513600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Early detection of iron-deficiency anemia (IDA) can enhance the efficiency and effectiveness of clinical treatment and quality of life for end-stage renal disease (ESRD) patients. This study aimed to evaluate the validity of CHr and %Hypo in screening IDA among ESRD patients and compare their performance with screening IDA among non-ESRD patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A retrospective analysis of 312 participants was conducted at Cho Ray Hospital, Vietnam, including healthy control participants and ESRD patients. Receiver operator characteristics curves and the area under the curve (AUC) of models were used to evaluate the performance of CHr, %Hypo. Optimal cut-off values were determined using Youden\u2019s index.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Detecting IDA in ESRD patients is more complicated, as the screening performance of CHr and %Hypo in predicting IDA among ESRD patients were lower than non ESRD group, but still reasonable with AUC\u2009=\u20090.748 (95% CI: 0.656\u20130.840, power\u2009=\u20090.997) and 0.740 (95% CI: 0.647\u20130.833, power\u2009=\u20090.996), respectively. Cut-off values of CHr\u2009&lt;\u200931.5\u2009pg and %Hypo&gt;\u200910.0\u2009pg are recommended to obtain optimal screening ability for Vietnamese ESRD patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>CHr and %Hypo appears to be useful tools for screening IDA among both non ESRD and ESRD patients. The low cost and accessible of the two markers encourage their utility as effective screening tools in clinical practice.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12882-020-01796-8","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T16:03:42Z","timestamp":1587571422000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["The validity of reticulocyte hemoglobin content and percentage of hypochromic red blood cells for screening iron-deficiency anemia among patients with end-stage renal disease: a retrospective analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Nhan Hieu","family":"Dinh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne Monivong","family":"Cheanh Beaupha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loan Thi Anh","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"issue":"3","key":"1796_CR1","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1053\/j.ajkd.2017.09.026","volume":"71","author":"S Fishbane","year":"2018","unstructured":"Fishbane S, Spinowitz B. Update on anemia in ESRD and earlier stages of CKD: core curriculum 2018. Am J Kidney Dis. 2018;71(3):423\u201335.","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"1796_CR2","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1185\/030079904X2763","volume":"20","author":"W McClellan","year":"2004","unstructured":"McClellan W, Aronoff SL, Bolton WK, Hood S, Lorber DL, Tang KL, et al. The prevalence of anemia in patients with chronic kidney disease. Current medical research opinion. 2004;20(9):1501\u201310..","journal-title":"Current medical research opinion"},{"issue":"2","key":"1796_CR3","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/0003-4819-139-2-200307150-00013","volume":"139","author":"AS Levey","year":"2003","unstructured":"Levey AS, Coresh J, Balk E, Kausz AT, Levin A, Steffes MW, et al. National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Ann Intern Med. 2003;139(2):137\u201347.","journal-title":"Ann Intern Med"},{"issue":"8","key":"1796_CR4","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1001\/jama.294.8.924","volume":"294","author":"C Ullrich","year":"2005","unstructured":"Ullrich C, Wu A, Armsby C, Rieber S, Wingerter S, Brugnara C, et al. Screening healthy infants for iron deficiency using reticulocyte hemoglobin content. Jama. 2005;294(8):924\u201330.","journal-title":"Jama."},{"key":"1796_CR5","doi-asserted-by":"crossref","unstructured":"Bahrainwala J, Berns JS. Diagnosis of iron-deficiency anemia in chronic kidney disease. Seminars Nephrol. 2016;36(2):94\u20138.","DOI":"10.1016\/j.semnephrol.2016.02.002"},{"issue":"1","key":"1796_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2215\/CJN.01630408","volume":"4","author":"LA Rocha","year":"2009","unstructured":"Rocha LA, Barreto DV, Barreto FC, Dias CB, Moys\u00e9s R, Silva MRR, et al. Serum ferritin level remains a reliable marker of bone marrow iron stores evaluated by histomorphometry in hemodialysis patients. Clin J Am Soc Nephrol. 2009;4(1):105\u20139..","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"1796_CR7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.7196\/SAMJ.2016.v106i1.9934","volume":"106","author":"E Schapkaitz","year":"2016","unstructured":"Schapkaitz E, Buldeo S, Mahlangu JN. Diagnosis of iron deficiency anaemia in hospital patients: use of the reticulocyte haemoglobin content to differentiate iron deficiency anaemia from anaemia of chronic disease. S Afr Med J. 2016;106(1):53\u20134.","journal-title":"S Afr Med J"},{"issue":"3","key":"1796_CR8","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1034\/j.1600-0609.2002.01532.x","volume":"68","author":"S Kotisaari","year":"2002","unstructured":"Kotisaari S, Romppanen J, Penttil\u00e4 I, Punnonen K. The Advia 120 red blood cell and reticulocyte indices are useful in diagnosis of iron-deficiency anemia. Eur J Haematol. 2002;68(3):150\u20136.","journal-title":"Eur J Haematol"},{"issue":"2","key":"1796_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.bjhh.2015.02.004","volume":"37","author":"ABB Torino","year":"2015","unstructured":"Torino ABB, Gilberti MFP, Ed C, GAFd L, HZW G. Evaluation of erythrocyte and reticulocyte parameters as indicative of iron deficiency in patients with anemia of chronic disease. Rev Bras Hematol Hemoter. 2015;37(2):77\u201381.","journal-title":"Rev Bras Hematol Hemoter"},{"issue":"4","key":"1796_CR10","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1182\/blood.V99.4.1489","volume":"99","author":"AE Mast","year":"2002","unstructured":"Mast AE, Blinder MA, Lu Q, Flax S, Dietzen DJ. Clinical utility of the reticulocyte hemoglobin content in the diagnosis of iron deficiency. Blood. 2002;99(4):1489\u201391.","journal-title":"Blood."},{"issue":"4","key":"1796_CR11","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1053\/j.ajkd.2015.11.012","volume":"67","author":"LE Ratcliffe","year":"2016","unstructured":"Ratcliffe LE, Thomas W, Glen J, Padhi S, Pordes BA, Wonderling D, et al. Diagnosis and management of iron deficiency in CKD: a summary of the NICE guideline recommendations and their rationale. Am J Kidney Dis. 2016;67(4):548\u201358.","journal-title":"Am J Kidney Dis"},{"issue":"Supplement 1","key":"1796_CR12","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.2215\/CJN.01490506","volume":"1","author":"JB Wish","year":"2006","unstructured":"Wish JB. Assessing iron status: beyond serum ferritin and transferrin saturation. Clin J Am Soc Nephrol. 2006;1(Supplement 1):S4\u20138.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"1796_CR13","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1373\/49.10.1573","volume":"49","author":"C Brugnara","year":"2003","unstructured":"Brugnara C. Iron deficiency and erythropoiesis: new diagnostic approaches. Clin Chem. 2003;49(10):1573\u20138.","journal-title":"Clin Chem"},{"issue":"7","key":"1796_CR14","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1093\/ndt\/16.7.1416","volume":"16","author":"N Tessitore","year":"2001","unstructured":"Tessitore N, Solero GP, Lippi G, Bassi A, Faccini GB, Bedogna V, et al. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrol Dialysis Transplant. 2001;16(7):1416\u201323.","journal-title":"Nephrol Dialysis Transplant"},{"issue":"10","key":"1796_CR15","doi-asserted-by":"publisher","first-page":"e0204899","DOI":"10.1371\/journal.pone.0204899","volume":"13","author":"AM Nalado","year":"2018","unstructured":"Nalado AM, Mahlangu JN, Duarte R, Paget G, Olorunfemi G, Jacobson BF, et al. Utility of reticulocyte haemoglobin content and percentage hypochromic red cells as markers of iron deficiency anaemia among black CKD patients in South Africa. PLoS One. 2018;13(10):e0204899.","journal-title":"PLoS One"},{"issue":"4","key":"1796_CR16","first-page":"241","volume":"11","author":"K Jimenez","year":"2015","unstructured":"Jimenez K, Kulnigg-Dabsch S, Gasche C. Management of iron deficiency anemia. Gastroenterol Hepatol. 2015;11(4):241.","journal-title":"Gastroenterol Hepatol"},{"issue":"1","key":"1796_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/kisup.2012.77","volume":"3","author":"G Eknoyan","year":"2013","unstructured":"Eknoyan G, Lameire N, Eckardt K, Kasiske B, Wheeler D, Levin A, et al. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3(1):5\u201314.","journal-title":"Kidney Int"},{"issue":"2","key":"1796_CR18","doi-asserted-by":"publisher","first-page":"153","DOI":"10.4274\/Tjh.2012.0107","volume":"30","author":"M Karag\u00fclle","year":"2013","unstructured":"Karag\u00fclle M, G\u00fcnd\u00fcz E, Mutlu F\u015e, Akay MO. Clinical significance of reticulocyte hemoglobin content in the diagnosis of iron deficiency anemia. Turk J Hematol. 2013;30(2):153.","journal-title":"Turk J Hematol"},{"key":"1796_CR19","first-page":"ii1","volume":"19","author":"F Locatelli","year":"2004","unstructured":"Locatelli F, Aljama P, Barany P, Canaud B, Carrera F, Eckardt K, et al. Revised European best practice guidelines for the management of anaemia in patients with chronic renal failure. Nephrol Dialysis Transplant. 2004;19:ii1.","journal-title":"Nephrol Dialysis Transplant"},{"issue":"1","key":"1796_CR20","doi-asserted-by":"publisher","first-page":"e0191541","DOI":"10.1371\/journal.pone.0191541","volume":"13","author":"M Aoun","year":"2018","unstructured":"Aoun M, Karam R, Sleilaty G, Antoun L, Ammar W. Iron deficiency across chronic kidney disease stages: is there a reverse gender pattern? PLoS One. 2018;13(1):e0191541.","journal-title":"PLoS One"},{"issue":"1","key":"1796_CR21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1751-553X.2007.00901.x","volume":"30","author":"J Kim","year":"2008","unstructured":"Kim J, Ihm C, Kim H. Evaluation of reticulocyte haemoglobin content as marker of iron deficiency and predictor of response to intravenous iron in haemodialysis patients. Int J Lab Hematol. 2008;30(1):46\u201352.","journal-title":"Int J Lab Hematol"},{"key":"1796_CR22","doi-asserted-by":"crossref","unstructured":"Chhabra G, Gochhait S. Iron deficiency anemia: An insight into new screening parameters. Commun Family Med. 2017;3(01):32\u20134.","DOI":"10.4103\/2395-2113.251866"},{"key":"1796_CR23","doi-asserted-by":"crossref","unstructured":"Urrechaga E, Borque L, Escanero JF. Biomarkers of hypochromia: the contemporary assessment of iron status and erythropoiesis. Biomed Res Int. 2013;2013:1\u20136.","DOI":"10.1155\/2013\/603786"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01796-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-01796-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-01796-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T13:02:40Z","timestamp":1722776560000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-01796-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1796"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-01796-8","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,22]]},"assertion":[{"value":"28 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study has been approved by the Biomedical Research Ethics Committee at the University of Medicine and Pharmacy at Ho Chi Minh City, Vietnam (Approval number: 415\/DHYD-HD, December 1, 2016).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}